E. D. Klerk

COMPLIANCE MONITORING OF NSAID DRUG THERAPY IN ANKYLOSING SPONDYLITIS, EXPERIENCES WITH AN ELECTRONIC MONITORING DEVICE

S. Linden, E. D. Klerk, 1996 .

Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatin

E. Lesaffre, B. Vrijens, A. Belmans, 2006, Pharmacoepidemiology and drug safety.

Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.

M. Dougados, S. van der Linden, D. M. van der Heijde, 1999, The Journal of rheumatology.

Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects.

E. D. de KLERK, P. Sterk, H. Smits, 1997, American journal of respiratory and critical care medicine.

Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy.

D. Heijde, S. Linden, H. Tempel, 1999 .

Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

J Urquhart, J. Urquhart, E. D. de KLERK, 1998, Statistics in medicine.

Dose timing information improves the clinical exploratory power of data on patient compliance with antiretroviral drug regimens

E. Goetghebeur, J. Urquhart, R. Gross, 2002 .